Leadership Summit returns for this year's CPHI Milan show

The C-suite programme brings senior pharma decision-makers together to address geopolitical fragmentation, domestic manufacturing priorities and policy translation across four interconnected strategic themes

The Leadership Summit will be returning to this year's CPHI trade show, held in Milan from Oct 6-8.

The summit will take place on the first day of the show, bringing together C-suite executives, senior vice presidents, founders and other senior pharma decision-makers to discuss how geopolitical, policy and manufacturing shifts are reshaping the industry.

 The full speaker line-up is available here.

The pharmaceutical sector is entering a period in which resilience, medicine security and manufacturing capability are becoming increasingly important strategic priorities.

Geopolitical fragmentation, resource nationalism and pressure to secure domestic access to critical medicines are prompting companies to reassess where and how medicines are sourced, manufactured and supplied.

The summit is intended to explore how the industry can translate a rapidly changing global environment into practical strategy.


This year’s programme will focus on the following four interconnected areas shaping pharma’s next phase:

  • strategic industry transformation
  • supply chain resilience
  • translating policy into practice
  • and the infrastructure required to support future pharmaceutical innovation.

The discussions will focus on the operational implications of growing government focus on domestic medicine access and security, among other forces driving change across the sector.

Supply chain resilience will also be a central theme of the talks, exploring how geopolitical fragmentation and resource nationalism are influencing sourcing strategies and challenging established supply models.

The discussions will also look ahead to the future, exploring whether pharmaceutical manufacturing and supporting infrastructure can keep pace with scientific innovation, as well as the implications of medicines increasingly being viewed as strategic national assets.

Tara Dougal, Event Director for CPHI Milan, said: “The pharmaceutical industry is having to make strategic decisions against an evolving backdrop."

"Questions around where medicines are made, how supply chains are secured and how companies respond to changing policy expectations are becoming increasingly interconnected."

The Leadership Summit creates a space for senior decision-makers to have candid conversations about those pressures, share how they are responding in practice and consider what they mean for the future direction of the industry.

Visitors to this year's CPHI can register here to secure a Leadership Summit pass.

You may also like